Recruiting

Observational Study

Sponsor:

American Heart Association

Code:

NCT06245187

Conditions

Atrial Fibrillation

Atrial Flutter

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

GWTG Atrial Fibrillation program

Study Details

Brief summary:

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Conditions

Atrial Fibrillation

Atrial Flutter

Study ID

NCT06245187

Start date

Jan, 2013

Status verified date

Jan, 2024

Completion date

Jan, 2040

Anticipated

Primary completion date

Jan, 2040

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria:

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
  • Patients under 18 years of age
  • Patients not admitted as inpatients.
  • Patients on comfort care only
  • Patients discharged to hospice.

Study Design

Enrollment

17198 participants

Anticipated

Interventions and Outcome Measures

Interventions

GWTG Atrial Fibrillation program

Evidence based recommended therapies and counseling prior to hospital discharge.

Primary outcome measure

  • Cardiac Tamponade and/or Pericardiocentesis Following Ablation [ Time Frame: 30 days ]

Central Contacts and Locations

Central contacts

Amy Bennett, JD

214-706-2237amy.bennett@heart.org

Christine Rutan

Christine.Rutan@heart.org

Locations

Amy Bennett

Recruiting

Dallas, Texas, United States, 75231

Contacts

Amy Bennett, JD

214-706-4881amy.bennett@heart.org

Christine Rutan

Christine.Rutan@heart.org

More Information

Sponsor

American Heart Association

Last update posted

Jan 29, 2025

Last verified

Jan, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by American Heart Association on 2025-01-29.